Business Wire

Mavenir Introduces Mobile Business Fabric™ to Transform Business Communications for Deskless Mobile Workers

8.10.2019 15:00:00 EEST | Business Wire | Press release

Share

Mavenir, the industry’s only end-to-end, cloud-native Network Software Provider, today announced its Mobile Business Fabric™, a dynamic and fluid business communications framework designed to meet the evolving digital needs of businesses as mobility becomes a primary driver and customers demand change.

Mavenir’s Mobile Business Fabric™ consists of a portfolio of integrated business solutions with a focus on enabling deskless, mobile workers for businesses of all sizes—from SMBs to large enterprises. This portfolio integrates mobile voice, mobile video, rich communication services (RCS) and SMS messaging, voicemail, interactive voice response (IVR), chatbots, SpamShield™ fraud management and monetization enablers into secure, carrier-grade cloud offerings.

These are combined with digital enablement capabilities for provisioning, onboarding, and invoicing businesses via an intuitive, omnichannel interface. This embedded functionality avoids long, complex and costly integrations with the existing legacy business support systems (BSS) of the service provider or channel partner, accelerating time-to-market and time-to-revenue.

Mavenir’s Mobile Business Fabric solutions are currently deployed and under deployment in several Tier 1 MNOs in the US, UK, Spain, Germany, India and Japan.

“Mavenir’s vision is to transform mobile network economics and accelerate the business transformation for mobile operators and channel partners,” said Guillaume Le Mener, SVP and GM, Mobile Enterprise Solutions, Mavenir. “Mobile Business Fabric is a cohesive portfolio that provides true mobile-native experiences and addresses the deskless mobile user base to generate additional revenue streams, protect their existing customer base and reduce customer churn.”

Supporting Information:

  • Today, 80% of the global workforce are mobile “deskless” first line workers and the top 8 deskless industries—agriculture, education, healthcare, retail, hospitality, manufacturing, transportation and construction—employ 2.7 billion employeesi.
  • Deskless mobile workers require simplified workflows leveraging their powerful mobile devices on the go.
  • Today, the majority of solutions in the market have been designed for office workers and then adapted to include some limited mobility capabilities. This can lead to user frustration, particularly for emerging mobile small and medium businesses (SMBs), which have been underserved.

Mavenir’s Mobile Business Fabric flips the paradigm over with a mobile-native portfolio that doesn’t require IT administrators, hardware investments, or complex device management, while providing seamless onboarding to help accelerate time to revenue.

“As an innovative and agile Software as a Service (SaaS) solution, Mavenir’s Mobile Business Fabric portfolio enables our global partners to target the Enterprise market, as well as the underserved SMB segment,” said Marek Wasilewski, SVP, Global Enterprise Channel. “Our disruptive solutions designed for the deskless mobile workers—who typically have an I want to do it myself and I want it now mentality—simplify onboarding, remove management complexity, and, ultimately, are focused on adding positive business outcomes."

The Mobile Business Fabric portfolio comes to market with the following solutions:

  • Mobile Business Messaging — RCS Business Messaging as a service that enables MNOs to address the brands’ need to communicate with customers on the mobile messaging channel—including marketing campaigns (A2P) and chatbots (P2A)—leveraging Mavenir’s RBM Partner Ecosystem to accelerate time-to-revenue.
  • Mobile Business Contact — Helping businesses of all sizes to minimize the number of missed business opportunities with a white label omni-channel contact center as a service (CCaaS) designed for quick and easy access. It enables seamless omni-channel (phone, email, chat, text-message, social) interactions with customers; with fast deployment using pre-built templates and API integrations with popular tools and AI platforms.
  • Mobile Business Communications and Collaboration — unified communications and collaboration as a service (UCaaS) built on mobile call control elements, that leverages mobile network quality of service (QoS) enforcement as well as RCS messaging to allow businesses to text with both internal and external users, breaking the traditional restrictions of proprietary instant messaging implementations.

The Mobile Business Fabric solutions announced are available today as a service hosted from the Mavenir cloud or deployed in the service provider’s network. Mavenir is already adapting more products and solutions into the Fabric, expected in early 2020.

To learn more, visit Mavenir's Mobile Business Fabric page.

NOTE: Mavenir will be showcasing Mobile Business Fabric with live demos at Mobile World Congress 2019 Los Angeles. To request a meeting, visit https://mavenir.com/buzz/events/mwc-la-2019

About Mavenir:

Mavenir is the industry's only end-to-end, cloud-native network software provider. Focused on accelerating software network transformation and redefining network economics for Communications Service Providers (CSPs) by offering a comprehensive end-to-end product portfolio across every layer of the network infrastructure stack. From 5G application/service layers to packet core and RAN – Mavenir leads the way in evolved, cloud-native networking solutions enabling innovative and secure experiences for end users. Leveraging industry-leading firsts in VoLTE, VoWiFi, Advanced Messaging (RCS), Multi-ID, vEPC, and Virtualized RAN, Mavenir accelerates network transformation for more than 250+ CSP customers in over 130 countries, which serve over 50% of the world’s subscribers.

We embrace disruptive, innovative technology architectures and business models that drive service agility, flexibility, and velocity. With solutions that propel NFV evolution to achieve web-scale economics, Mavenir offers solutions to help CSPs with cost reduction, revenue generation, and revenue protection. Learn more at mavenir.com

Mavenir, the M logo, and CloudRange are trademarks owned by Mavenir Systems, Inc.

Copyright © 2019 Mavenir Systems, Inc. All Rights Reserved.

i Emergence: Rise of the Deskless Workforce, 2018

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Maryvonne Tubb
Mavenir
PR@mavenir.com

Loren Guertin
MatterNow
mavenir@matternow.com

Kevin Taylor
GlobalResultsPR
mavenir@globalresultspr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 14:30:00 EEST | Press release

Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye